Bookmark and Share
mu-type opioid receptor isoform MOR-1 [Homo s.. [gi:117940060] - Target BioActivity Data
Also known as: mu-type opioid receptor isoform MOR-1 [Homo sapiens].
BioActivity Outcomes:
Active(2591)
 
 
Inactive(675691)
 
 
Unspecified(2)
 
 
BioAssay Types:
Screening(677193)
 
 
 
Confirmatory(1088)
 
 
 
BioActivity Types:
EC50(1063)
 
 
 
IC50(25)
 
 
 
Substance Types:
Chemical(678284)
 
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 20    Data Row: 678284   Total Pages: 33915   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayLinks
OutcomeTypeValue [μM]
1
[SID26670736]
[CID661788]
EC50 0.01406Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
2
[SID85273843]
[CID44246752]
EC50 0.01406Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
3
[SID56463128]
[CID16219954]
EC50 0.04226Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
4
[SID49672140]
[CID16288533]
EC50 0.04588Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
5
[SID93576955]
[CID4749]
EC50 0.12678Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
6
[SID24784258]
[CID16188374]
EC50 0.12678Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
7
[SID85273815]
[CID64761]
EC50 0.13204Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
8
[SID24800620]
[CID16192289]
EC50 0.15116Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
9
[SID49674907]
[CID16326480]
EC50 0.20015Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
10
[SID144241345]
[CID10407491]
EC50 0.206Late-stage results from the probe development effort to identify activators of OPRM1 and OPRD1 heterodimer formation: luminescence-based cell-based dose response assay, Set 2 [AID651762, Type: confirmatory]
View
11
[SID47197229]
[CID23723457]
EC50 0.22694Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
12
[SID17515694]
[CID3606260]
EC50 0.30341Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
13
[SID144087319]
[CID60156214]
IC50 0.323Late-stage results from the probe development effort to identify antagonists of OPRK1: luminescence-based cell-based dose response OPRM1 counterscreen [AID652034, Type: confirmatory]
View
14
[SID24832814]
[CID4391932]
EC50 0.37506Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
15
[SID51086057]
[CID24891945]
EC50 0.38052Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
16
[SID17515001]
[CID12005930]
EC50 0.38096Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
17
[SID144241350]
[CID25374006]
EC50 0.394Late-stage results from the probe development effort to identify activators of OPRM1 and OPRD1 heterodimer formation: luminescence-based cell-based dose response assay, Set 2 [AID651762, Type: confirmatory]
View
18
[SID134220670]
[CID23723457]
EC50 0.403Late-stage results from the probe development effort to identify activators of OPRM1 and OPRD1 heterodimer formation: luminescence-based cell-based dose response assay [AID651685, Type: confirmatory]
View
19
[SID24812061]
[CID5113104]
EC50 0.40787Luminescence-based cell-based high throughput dose response assay for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors [AID588407, Type: confirmatory]
View
20
[SID144087321]
[CID60156232]
IC50 0.479Late-stage results from the probe development effort to identify antagonists of OPRK1: luminescence-based cell-based dose response OPRM1 counterscreen [AID652034, Type: confirmatory]
View